SEC Filing Summary: Nukkleus Inc. (NUKK)
Business Context and Reporting Period
This Form 8-K reports on the completion of Nukkleus Inc.'s 2025 Annual Meeting of Stockholders held on November 6, 2025. The registrant is an emerging growth company incorporated in Delaware, with common stock and warrants trading on The Nasdaq Stock Market LLC. The filing details the voting results for three specific proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and shareholder voting outcomes rather than financial performance data.
Material Changes and Voting Results
At the Annual Meeting, 5,135,897 shares were present or represented by proxy, constituting a quorum out of 13,550,766 shares entitled to vote. The following actions were taken:
- Election of Directors: All five nominees (Menachem Shalom, David Rokach, Tomer Nagar, Aviva Volodarsky, and Reuven Yeganeh) were elected. Menachem Shalom received the highest support with 5,125,178 votes FOR, while David Rokach received the most WITHHELD votes at 206,972.
- Ratification of Auditors: Shareholders approved the appointment of Somekh Chaikin (a member firm of KPMG International) as the independent external auditors for the year ending December 31, 2025. The vote was 5,120,639 FOR, 10,837 AGAINST, and 4,421 ABSTAIN.
- Equity Incentive Plan: Shareholders approved the 2025 Equity Incentive Plan, authorizing the issuance of 3,950,000 shares of Common Stock. The vote was 4,830,626 FOR, 302,091 AGAINST, and 3,180 ABSTAIN.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, or contingencies. The document is limited to the procedural results of the shareholder vote.
Key Facts for Investor Verification
- Verify the impact of the newly authorized 3,950,000 shares under the 2025 Equity Incentive Plan on existing shareholder dilution.
- Confirm the tenure and specific roles of the five newly elected directors.
- Review the upcoming 2025 annual report to assess the financial performance of the company, as no financial metrics were included in this 8-K.
- Note the relatively high number of withheld votes for director David Rokach (206,972) compared to other nominees.